Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728754 · ClinicalTrials.gov registry record · NA
A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.
A NA study of Partial-edentulism and Tooth Disease, sponsored by ZimVie.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT00728754 is a NA study of Partial-edentulism and Tooth Disease that has completed, run by ZimVie. The registered enrollment target is 61 participants, above the 51-participant average among 3 other Partial-edentulism trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00728754, a NA study of Partial-edentulism and Tooth Disease, has completed, sponsored by ZimVie.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective, randomized study will evaluate the performance of the Osseotite Certain Prevail implant when compared to that of the non-lateralized version of the implant. Study (null) hypothesis: the crestal bone changes that take place after placement and loading of the Osseotite lateralized implants will be the same as for a similar but non-lateralized Osseotite Certain implant.
Conditions Studied
Interventions
- DEVICE Dental implant Osseotite Prevail
- DEVICE Dental implant Osseotite
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2005-03 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00728754
The ClinicalTrials.gov registry entry for NCT00728754 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 51-participant average among 3 other Partial-edentulism trials with a reported enrollment target (20% higher). The listed sponsor is ZimVie, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Partial-edentulism appearing as the primary indexed condition, and to 2 interventions - of which Dental implant Osseotite Prevail is the first listed.
NCT00728754 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00728754 about?
NCT00728754 is a clinical study titled "A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.". This prospective, randomized study will evaluate the performance of the Osseotite Certain Prevail implant when compared to that of the non-lateralized version of the implant. Study (null) hypothesis: the crestal bone changes that take place after placement and loading of the Osseotite lateralized i...
What is the current status of trial NCT00728754?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2005-03. Estimated completion is 2011-04.
What conditions does trial NCT00728754 study?
This clinical trial studies the following conditions: Partial-edentulism, Tooth Disease.
What interventions are being tested in trial NCT00728754?
The interventions under investigation include: Dental implant Osseotite Prevail (DEVICE), Dental implant Osseotite (DEVICE).
Who is sponsoring clinical trial NCT00728754?
This trial is sponsored by ZimVie, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00728754 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Partial-edentulism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.